t is well known that contraction of the heart is signaled by an increase of intracellular calcium concentration ([Ca 2+ ]i) from a resting or diastolic level of approximately 100 nmol/L to peak systolic levels of approximately 1 μmol/L (see References 1-5 for reviews). A major factor determining the strength of the force of contraction is the amplitude of this systolic Ca transient; for example, the positive inotropic effect of β-adrenergic stimulation results from an increase of the amplitude of the systolic Ca transient.
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There are 2 sources of the calcium that activates contraction: (1) Ca entry from the extracellular environment during the action potential, largely via the L-type Ca current, and (2) Ca released from the intracellular Ca 2+ store, the sarcoplasmic reticulum (SR) ( Figure 1A ). In mammalian cardiac muscle, release from the SR accounts for the majority of the Ca required for contraction. The release of Ca 2+ from the SR occurs in response to a small increase of Ca 2+ concentration immediately adjacent to the SR Ca 2+ release channel, the ryanodine receptor (RyR). This initial increase of [Ca 2+ ]i is due to Ca 2+ entering the cell during the action potential on the L-type Ca 2+ current. As the release process is Ca 2+ dependent, it is termed Ca 2+ -induced Ca 2+ release (CICR). The opening of individual clusters of RyRs can be observed from the resulting brief increases of [Ca 2+ ]i and have been termed "Ca sparks". 6 Ordinarily, all the SR Ca 2+ release units are synchronized to release Ca 2+ "simultaneously" to produce the systolic rise of [Ca 2+ ]i. 7 Although there are significant functional, structural and molecular differences between atrial and ventricular myocytes that result in differences in the spatiotemporal properties of the systolic Ca 2+ transient, [8] [9] [10] the SR is still the main source of Ca 2+ in the atria. 11 As well as being activated and regulated by cytoplasmic Ca, opening of the RyR is also increased by an increase of the Ca concentration in the SR (so called "luminal" Ca). [12] [13] [14] As a consequence, an increase of luminal Ca leads to an increase of the amplitude of the systolic Ca transient ( Figure 1B) . [15] [16] [17] This relationship between SR Ca content and systolic Ca has both physiological and pathological consequences. Physiologically, it contributes to the positive inotropic effects of SERCA stimulation during β-adrenergic stimulation 18 or increases of heart rate. 19, 20 One pathological consequence is seen in heart failure, in which a decrease of SR Ca content results in a decrease of the amplitude of the systolic Ca transient. [21] [22] [23] Quantitative analysis has shown that in heart disease the fractional decrease of the systolic Ca transient is greater than that of the SR Ca content, 23 a result that is to be expected from the steep dependence of Ca release on SR Ca content. 17, 24 
Calcium Overload and Waves
Circumstances that increase the amount of Ca in the SR excessively result in a situation known as "calcium overload". The hallmark of this Ca overload is the occurrence of propagating waves of CICR (Figures 2A,B) . [25] [26] [27] [28] [29] Much research has elucidated how Ca overload and waves develop. The first stage is an increase in Ca loading of the SR, which can arise because of increased loading of the cell with Ca 2+ as a consequence of an imbalance between Ca 2+ entry and efflux. 16, 24 This will result in an increase of SR Ca content ( Figure 2C ). It appears that the increased SR Ca content results in an increased frequency of Ca sparks and thence in the initiation of Ca waves. 30 As shown in Figure 2A , for a Ca wave to occur, the Ca released from a point in the SR must be able to diffuse through the cytoplasm and trigger release from another region. 31, 32 It is interesting to consider which factors determine when waves occur. It appears that there must be a high enough frequency of Ca sparks in a given volume of the cell. It has been suggested that the Ca released by a single spark will be taken up by cytoplasmic buffers and will therefore be unable to activate further release. Once the wave has been initiated, the greater the SR Ca content, the greater the amount released and the more likely a wave is to propagate. 30 The properties of the RyR also determine the SR Ca threshold; for example, the addition of caffeine, which increases the open probability of the RyR, 33 decreases the threshold 34 ( Figure 2C ). Conversely, tetracaine, which decreases RyR opening, 35, 36 increases threshold. 37 Diastolic Ca 2+ waves are thought to underlie certain forms of arrhythmia as a result of some of the calcium in the wave being pumped out of the cell by the Na-Ca exchange (NCX). 38 The resultant NCX current will depolarize the cell and can result in a delayed afterdepolarization (DAD). 39, 40 
Arrhythmias Caused by Calcium Overload
Cardiac glycosides have a long history as inotropic agents, and DADs were first identified in the etiology of triggered arrhythmias as a result of digitalis intoxication. The inotropic actions of cardiac glycosides are an indirect consequence of Na + /K + ATPase inhibition increasing [Na + ]i and thus reversing the NCX to increase SR Ca 2+ content. 41, 42 It is this increase of SR Ca 2+ content that can produce Ca 2+ waves and thence arrhythmias (see Venetucci et al 43 for review).
Ventricular Outflow Tract Tachycardia
This arrhythmia accounts for approximately 70% of the cases of ventricular tachycardia (VT) in patients without structural heart disease. 44 In approximately 90% of cases it originates from the right ventricular outflow tract (RVOT), 45 showing a classical pattern of left bundle branch morphology and inferior axis deviation. It is caused by abnormalities in the metabolism of cyclic AMP (cAMP is the main intracellular messenger of β-adrenergic stimulation). These alterations in cAMP metabolism are postulated to lead to cellular Ca overload and thence, by the same mechanisms described previously, DADs. 44 In the majority of cases the RVOT tachycardia is induced by exertion and can be terminated by a bolus of adenosine. Adenosine binds to its A1 receptor, which couples with the inhibitory G protein (Gi). 46 Activation of Gi inhibits adenyl cyclase (the enzyme that synthesizes cAMP) and reduces the intracellular levels of cAMP. The reduction in cAMP will affect several downstream targets, including the L-type Ca 2+ channel and SR Ca 2+ ATPase, and subsequently decrease SR Ca content and thus terminates the tachycardia.
Catecholaminergic Polymorphic VT (CPVT)
Another situation in which Ca waves have been suggested to lead to arrhythmias is in CPVT. Patients with CPVT develop VTs on exercise or during emotional stress (ie, when circulating catecholamines are increased). 47 CPVT was first associated with mutations in the RyR, 48, 49 which is an autosomal dominant form of the disease. More recently, a recessive form has been described in which the underlying mutation occurs in the SR Ca buffer, calsequestrine. 50 A detailed summary of RyR mutations involved with CPVT is provided by George et al 51 and Yano. 52 As well as ventricular arrhythmias, patients with CPVT also show atrial arrhythmias and sinoatrial node dysfunction. 53 Work on isolated RyRs has shown that the probability that they are open at low cytoplasmic concentrations is greater than for wild-type RyRs. 54, 55 It has also been shown that DADs are more likely to occur in cells that express either mutant RyRs or CSQ. 56, 57 Why is β-Adrenergic Stimulation Required to Produce CPVT? The question we have been interested in is why does the mutant RyR only produce arrhythmias in the presence of β-adrenergic stimulation? At a cellular level, this equates to why (in cells which express mutant RyRs) are Ca waves only seen in the presence of β-adrenergic stimulation? We have studied this question by increasing the RyR open probability by applying low concentrations of caffeine. 58 Figure 3A shows that the application of caffeine results in the initial production of a few waves. However, after the third stimulus no waves are seen. Therefore, in the steady state, waves are not seen in the presence of caffeine. The explanation for this, initially surprising, result is provided in the lower panel of Figure 3A . Here we have calculated the SR Ca content before each stimulus. Before adding caffeine, the Ca content is constant from beat to beat; however the Ca efflux on the waves in caffeine results in a net loss of Ca from the cell and therefore the SR. In the steady state the SR Ca content in caffeine is less than that in control. By the same token that an increase of SR Ca results in the appearance of Ca waves, it is plausible that the decrease of Ca on caffeine application is responsible for the disappearance of Ca waves from the cell.
The fact that sensitizing the RyR with caffeine application does not produce Ca waves in the steady state is consistent with the fact that patients with RyR mutations do not have arrhythmias at rest. Given that these patients develop arrhythmias on β-adrenergic stimulation, we have investigated whether the effects of caffeine application are different in the presence of β-adrenergic stimulation. The experiment illustrated in Figure 3B shows that, in the presence of the β-agonist isoprenaline, the application of caffeine produces waves that persist. This result therefore mimics the phenotype of CPVT. The remaining question is why does caffeine application produce sustained Ca waves in the presence of a β-agonist? There are at least 2 possible SR-related explanations for the presence of Ca 2+ waves only occurring in the presence of isoprenaline: β-adrenergic stimulation could (1) increase SR Ca content by stimulating SERCA or (2) phosphorylate the RyR thus making it leaky. 59 A third possibility that might contribute to the arrhythmias occurring during β stimulation is that the L-type Ca 2+ current is also increased and could increase SR content. However, we have shown previously that changes of L-type Ca 2+ alone have very little effect on SR Ca content. 24 This is because, although an increase of L-type Ca current loads the cell and SR with Ca, it also triggers more release from the SR, thereby depleting it and the two effects are balanced. 60 Considering therefore the role of SERCA and the RyR during β-adrenergic stimulation, an effect attributable solely to the RyR is made less likely by the observation ( Figure 3A ) that increasing RyR po does not itself produce Ca waves in the steady state. It is still, however, necessary to distinguish between these alternatives. The results of Figure 3C show that the SR Ca content is increased by isoprenaline. This result is more consistent with the idea that β-adrenergic stimulation produces waves by increasing SR content rather than by lowering the threshold for release. Further evidence for the importance of SR Ca content is presented in Figure 4A . Here the cell was ex- 58 RyR, ryanodine receptor.
Circulation Journal Vol.73, September 2009
posed to isoprenaline (1 μmol/L) and caffeine (0.5 mmol/L) throughout the record shown. Before the trace that is illustrated, the cell had been exposed to a high concentration of caffeine (10 mmol/L) to empty the SR of caffeine. After removing the caffeine, stimulation was recommenced. Initially, the Ca transients were very small because of the reduced SR Ca content. The lower trace shows the SR Ca content calculated from the sarcolemmal Ca fluxes (see Venetucci et al 58 for details). As can be seen, the recovery of SR Ca content is accompanied (and presumably caused) by an increase of SR content. It is also clear that the Ca waves only develop when SR Ca content has almost reached its steady state. In other words, the increase of SR Ca content is necessary for the appearance of Ca waves, because even a small decrease of SR Ca abolishes the waves, despite the fact that the cell is still exposed to caffeine and isoprenaline. Figure 4B shows the different dependencies of the Ca transient and Ca wave on SR content. The Ca transient increases at lower SR Ca contents before reaching a maximum value. In contrast, as discussed before, Ca waves are seen only above a threshold SR Ca content.
Clinical Aspects of CPVT The two arrhythmias associated with CPVT are bidirectional VT and polymorphic VT. 61 A recent study has suggested that bidirectional VT originates from the conducting system. 62 An issue that remains unresolved is if the alternating axis is because of two separate sites that alternate in initiating ventricular activity or related to a single focus situated in the HIS bundle that alternatively conducts down the left and right bundles. Mapping studies will resolve this issue.
Polymorphic VT associated with CPVT is characterized by a wide complex tachycardia with beats of variable morphology, but which does not have the rotating axis that is characteristic of torsades de pointes. In the great majority of cases, the foci that initiate the tachycardia are located in the right ventricle. 63 This observation could be explained by the fact that the right ventricle has less Ik1 (the potassium current that sets diastolic membrane potential) and it is easier for Ca waves to depolarize the cell and trigger an action potential. 64 A small number of patients with mutations of RyR directly develop VF during exercise. 61 It has been suggested that in these cases the mutation causes a loss of function of RyR, which predisposes to the development of Ca transient and action potential alternans. This could provide the substrate for the development of VF. 65 As an attractive hypothesis it still needs more experimental evidence. 
Calcium and Arrhythmias in Heart Failure
There is good evidence that DADs contribute significantly to many ventricular arrhythmias seen in heart failure (see Pogwizd et al 66 for review). A study of a small group of patients with dilated cardiomyopathy demonstrated that in these patients arrhythmias are caused not by macroreentry but by a focal mechanism suggested to involve DADs and triggered activity. 67 Therefore, a paradox exists between the reduction of SR Ca 2+ content observed in heart failure explaining the smaller contraction and the increased prevalence of arrhythmias in heart failure for which much previous evidence suggests that these occur when SR Ca 2+ content is increased. A potential explanation for this dichotomy is based on the following experimental observations. (1) When a wave does occur, the increase of NCX function in heart failure 23 will result in a larger depolarizing current and the concurrent decrease of the potassium current Ik1 66 will result in an even larger DAD. (2) It has been suggested that the properties of the RyR change in heart failure such that the threshold for Ca release is decreased. 68, 69 (3) Only the β1 response is lost, but the β2 response is enhanced and is able to increase SR Ca load. 70 In other words, waves will occur at a lower SR Ca content and adrenergic stimulation is still able to increase SR Ca content. 70 Although aspects of the mechanisms responsible are still controversial, 71 there is certainly an increase of Ca leakage from the SR. 72 
Treatment of Arrhythmias Resulting From Calcium Waves
The arrhythmias resulting from Ca waves could be treated either by abolishing the waves or by preventing the waves resulting in extrasystoles. The latter approach can be achieved with the use of conventional, local anesthetic antiarrhythmic agents. As regards abolishing Ca waves, it is worth noting that this approach is not without its possible problems. Ca waves produce a net loss of Ca from the cell 73, 74 and if the wave is removed some other method will have to be used to pump the Ca out of the cell. Unless sarcolemmal Ca removal processes are stimulated, this will require an increase of diastolic Ca, which may interfere with relaxation. 73 Nevertheless, in many situations this may be an acceptable price to pay for abolishing the arrhythmias. A drug that has been advanced is JTV519. 75, 76 Other approaches are based on the fact that some local anesthetic agents can decrease RyR opening 35 and thence abolish Ca waves. 37, 77 Indeed, the local anesthetic, tetracaine, abolishes Ca waves and the accompanying inward current. 78 Clinical use of tetracaine is precluded by the fact that, as well as decreasing RyR opening, it inhibits the sarcolemmal Na channel. A recent study has shown that another local anesthetic, flecainide, which also interacts with the RyR, can be used successfully to prevent CPVT arrhythmias in both mice and humans. 79 One might think that a compound that depresses RyR would have a negative inotropic effect; however, the Ca waves themselves decrease contractility and their removal may therefore actually increase contraction. 78 A reduction in SR Ca content could also abolish of Ca waves. Ca channel blockers decrease Ca influx. As mentioned before, this does not always decrease SR Ca 24 because the decreased trigger for Ca release will decrease Ca release and thereby maintain SR Ca content. If, however, the trigger is already supramaximal, then it is possible that Ca channel blockers will decrease SR Ca. There are reports that Ca channel blockers are effective in some cases of CPVT. 80 An alternative strategy is to decrease intracellular levels of cAMP, which will reduce SERCA activity, thereby decreasing SR Ca content.
Conclusions
It is now well established that Ca waves can result in clinically important ventricular arrhythmias. Recent work has emphasized that this can arise either because of an increase of SR Ca content or because of changes in the properties of the RyR. The challenge for the future is to increase our understanding of how the underlying Ca waves develop and to design therapies against the arrhythmias.
